Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

The treatment was effective for lupus nephritis with manageable side effects.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A cancer patient's hair became permanently curly after treatment with nivolumab.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Early recognition of symptoms is crucial for treating IPEX syndrome with a stem cell transplant.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Enhancing immune response can improve cancer treatment effectiveness.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.